Biological Clocks, Low-Cost Biomarkers, and AI for Healthspan Equity

Abstract

Biological clocks are central regulators of metabolism, immunity, cognition, and psychological well-being. Longevity medicine increasingly leverages sophisticated aging clocks, biomarker panels, and artificial intelligence (AI) analytics to support clients’ longevity efforts. These services are largely inaccessible to all but the most affluent populations. This paper qualitatively synthesizes recent research on biological clocks, health inequities, low-cost routine laboratory tests, and AI-enabled decision support to explore how rhythm-aligned, biomarker-driven, holistic wellness guidance can be made accessible to economically marginalized populations lacking consistent access to high end longevity medicine.

This research focused on a qualitative meta-synthesis of empirical and conceptual studies published between 2020 and 2025 targeting biological clocks, circadian health disparities, low-cost biomarkers, and AI-supported digital health in underserved communities. Twenty-two peer-reviewed articles met the inclusion criteria and were analyzed using a coding framework. Emergent themes included:

(1) biological clocks provide a cross-cutting framework linking healthspan to daily behaviors, social determinants, and
systemic inequities;
(2) circadian disruption and poor sleep health disproportionately affect low-income communities;
(3) standardized, low cost lab tests offer practical proxies for biological aging and healthspan risk;
(4) hair cortisol concentration (HCC) and related biomarkers provide a scalable window into chronic stress load in
marginalized settings;
(5) AI-enabled tools can translate routine lab data and symptoms into tailored, culturally grounded guidance aligned
with biological clocks; and
(6) structural barriers must be actively addressed to ensure that AI-supported rhythm-informed care reaches marginalized
communities.

Biological clocks and routine laboratories together create a “layman’s toolkit” that can be delivered at scale. When integrated into community-based health programs using low-cost digital platforms, these tools have the potential to extend healthspan for communities excluded from concierge longevity resources. Future research should evaluate the efficacy of these low-cost tools in a longitudinal study within marginalized societies.